ArticleTherapeutics and clinical risk management2017

Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysis.

Jan Sperl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.